Risk of thromboembolism in patients with COVID19 who are using hormonal contraception

Very little evidence exists on risk of VTE or increased COVID ‐19 severity for users of combined hormonal contraception (HC) vs. non‐users. Low certainty evidence suggests use of any HC method vs no contraceptive has little/no effect on hospitalization, intubation, or mortality.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news